Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Interchangeable biosimilars may cut costs or cause ‘cognitive dissonance’ Rob Volansky
-
- Benefit of biosimilar switching ‘less apparent’ to GIs, patients vs. third-party payers Edward V. Loftus Jr., MD
- ACG: ‘Early aggressive hydration’ essential to avoid complications in acute pancreatitis Kate Burba
- AGA guideline endorses FMT for recurrent C. difficile; ‘not yet advised’ for IBS, IBD Kate Burba
- FDA grants 510(k) clearance to Nanox AI software to assess ‘early signs’ of fatty liver
- FDA grants fast track status to investigational bepirovirsen for chronic hepatitis B
- Healthy lifestyle behaviors associated with up to 42% lower risk for IBS Kate Burba
- Higher dietary niacin intake linked to lower risk for all-cause mortality in MASLD Kate Burba
- ‘Monumental occasion’: FDA approves Madrigal’s Rezdiffra as first treatment for MASH Monica Stonehill
-
- Perioperative risk ‘should be of limited focus’ in choice of bariatric surgical procedure Kate Burba
- Topline data position GLP-1 newcomer survodutide as ‘potential leading treatment’ for MASH
- Tradipitant achieves ‘clinically meaningful outcomes’ in gastroparesis Kate Burba
- Up to 10% of veterans with dementia have FIB-4 scores that suggest undiagnosed cirrhosis Kate Burba
- VIDEO: 7 general principles ‘help to frame’ routine preventive vaccination in IBD Gil Y. Melmed, MD, MS; Kate Burba
- VIDEO: Inflammation likely ‘driving the risk’ for cardiovascular events in IBD Edward V. Loftus Jr., MD; Kate Burba
- VIDEO: OK to switch patients with IBD from biologic to biosimilar ‘at any given time’ Michael V. Chiorean, MD; Monica Stonehill
- VIDEO: Proven skills, decision-making help women ‘rise above’ bias in advanced endoscopy Kate Burba; Aileen Bui, MD; Jennifer Phan, MD
-
- VIDEO: ‘We all need to be concerned’ about consequences of inequity in health care Folasade P. May, MD, PhD, MPhil; Kate Burba